In 2015, the FDA removed the letter category system (A,B,C,D or X) from the product label of all prescription drugs. The letter category system first established in 1979 was regarded as overly simplistic and misinterpreted as a grading system. A new PLLR format was created to better aid in presenting the available safety data. In an attempt to assess awareness, understanding and value of the new PLLR, a survey formed in collaboration between the AAAAI and the FDA was distributed among the membership of the AAAAI. An online survey was sent to a random sample of the US membership of the AAAAI. The survey content consisted of questions addressing the following: demographics, awareness and use of the PLLR, understanding of the new PLLR format in example form, and the value of the new PLLR format. Of 1500 members who received an email survey, 184 (12%) completed the survey. Less than half of responders were aware that the pregnancy letter categories were replaced with a narrative summary. Most of the responders did not feel the new PLLR format was clear or concise, and almost all responders continued to use the pregnancy letter category system (A,B,C,D,or X) to make prescribing decisions. Inadequate management of chronic medical conditions during pregnancy can have profound effects on maternal and fetal health. This survey shows that most clinicians find the new label does not meets their needs in obtaining critical information for patient care.